The global coronavirus outbreak has tested people, industries, governments and supply chains unlike any crisis since World War II. Manufacturers and suppliers of personal protective equipment (PPE) have been working overtime to increase production in response to unprecedented international demand.

ISEA’s companies and the workers who make PPE are working hand in hand with the medical field as they strive to increase productivity while struggling with the same challenges, risks, and fears as the general public.

Members of the International Safety Equipment Association (ISEA) are working hard to keep everyone safe — including their own employees — during this difficult time. Our hearts, heads, and hands are unified in responding mightily to help America and the world’s extended family of nations obtain the PPE needed by healthcare workers.

Here are the latest ISEA statements on:

ISEA Contacts:

Nicole Randall
Marketing & External Affairs
[email protected]

Dan Glucksman
Public Affairs
[email protected]


The reasons are complex. Broadly speaking, no one knew a pandemic on this scale was coming. It has literally been a century since the last truly global health crisis.

In addition, over the past few decades, both for budgetary and efficiency reasons, healthcare organizations — just like most other sectors of the economy — adopted a “just in time” approach to ordering supplies. That philosophy worked until this crisis hit. There are policy solutions that can help to supply equipment during a crisis, some of which have been partially successful at this time, and others that were not in place. These range from stockpiling equipment to subsidizing inventory. ISEA has worked in the past and will work in the future to ensure that our country’s policies provide for an efficient and sufficient supply of safety equipment.


Yes. The Department of Homeland Security designated PPE an Essential industry in March 2020.

“Manufacturers, technicians, logistics and warehouse operators, and distributors of medical equipment, personal protective equipment (PPE), medical gases, pharmaceuticals (including materials used in radioactive drugs), blood and blood products, vaccines, testing materials, laboratory supplies, cleaning, sanitizing, disinfecting or sterilization supplies, and tissue and paper towel products.” 


Manufacturers engaged in a historic effort to ramp up production of the vital equipment needed to respond to the coronavirus outbreak. While respirators like N95 masks have received the greatest attention from the public and media, PPE needs also include protective garments, eye and face protection, gloves, and other components of the specialized ensembles health care professionals use to protect themselves.

Increasing Supply
Existing producers of vital PPE ramped up production, retooled existing lines, and partnered with government agencies to increase supply of the products they already make.

  • ISEA members have partnered with the federal government, which has placed orders for 500 million respirators, including N95s, surgical masks and surgical N95s. This addresses respirator shortages in the Strategic National Stockpile (SNS), through the vital funding and contract guarantees.
  • ISEA has made aware to leaders of the Strategic National Stockpile that attention must be paid to the Stockpile’s respirator shortage. The association fully supports the current SNS effort to acquire millions of surgical masks, N95 respirators and surgical N95 respirators.
  • PPE producers who specialize in products for other sectors such as industrial or construction protection have partnered with medical device producers to shift protection to products needed for outbreak response.
  • Manufacturers at large volunteering capacity for the effort, partnering with ISEA members to increase the volume of products that can be used for the response. 

Clearing More Supply for Use
To help address concerns about availability during the COVID-19 pandemic, the FDA has issued Emergency Use Authorizations (EUAs) for certain PPE products including face shields, other barriers, and respiratory protective devices such as respirators.

Additionally, the FDA has issued recommendations and policies about PPE which can be found here: Recent Final Medical Device Guidance Documents.


The CDC published an equivalent use chart that provides vital information for the use of imported respirators that are labeled with international standards.

Addressing Liability
As new PPE solutions are cleared for use, the liability that might slow or confuse hospitals, distributors, and manufacturers, is being addressed by FDA.

When a novel infectious agent causes a public health emergency and the government calls for PPE not usually found in hospitals, ISEA believes all such needed PPE must receive temporary, limited legal protection. This is because legal action resulting from compliance with federal and end-user requests for PPE not usually found in healthcare workplaces would likely result in fewer options for the next public health emergency. This includes protective coveralls, gloves, eye and face protection, and chemical protective aprons.


OSHA’s primary resource is the OSHA COVID-19 Official Webpage, which is frequently updated. Recent guidance released and housed on this page includes:

OSHA is issuing temporary guidance on the enforcement of its respiratory protection standard:


1. Paycheck Protection Program
As of April 15, the Small Business Administration (SBA) is no longer taking applications for the Paycheck Protection Program.

Frequently Asked Questions (FAQ) on the Paycheck Protection Program 

Access resources for assistance to small businesses, nonprofits, veterans organizations, and tribal businesses—as well as to certain self-employed folks and independent contractors.

2. FEMA Open Purchase Order for PPE
The FEMA contract opportunity for COVID-19 PPE and medical supplies was last updated April 2. Access the active order.

FEMA’s requisition specifies that products under consideration meet the requirements of ANSI/ISEA Z87.1-2010, American National Standard for Occupational and Educational Personal Eye and Face Protection.  ISEA has made ANSI/ISEA Z87.1-2010 available as a complimentary download to capture the widest distribution possible.

3. NIOSH Respiratory Protection
NPPTL Respirator Assessments: Results of efficiency listed here. (April 30)

NIOSH Guidance on Decontamination of Disposable Respirator (April 1)  

4. FDA Approvals
FDA program to allow non-NIOSH respiratory protective devices manufactured in China. (April 3)

FDA Approval for Battelle’s Vaporous Hydrogen Peroxide decontamination program for disposable respirators (March 29)

Other systems for decontaminating N95 respirators have received EUAs from FDA.  These EUA letters and FAQs about each process can be found here.

Approval of all other NIOSH-certified respirators for Hospital Use (March 28) 

This EUA states all NIOSH-certified respirators can be used in hospitals. FDA requires it be made aware of any adverse incidents of a respirator used in a medical setting.

FDA program to allow non-NIOSH respirators from Australia, Brazil, EU, Japan, Korea and Mexico (March 28)

No manufacturer has applied for this as of April 16.

FDA program to deem all NIOSH-certified respirators as Medical Devices and allowing their use in by healthcare professionals for COVID19 response (March 28)

5. COVID-19 PREP Act
PREP Act declaration for COVID19 (March 17, 2020) 
The broad listing of what’s covered is here:

Covered Countermeasures 42 U.S.C. 247d–6b(c)(1)(B), 42 U.S.C. 247d–6d(i)(1) and (7). Covered Countermeasures are any antiviral, any other drug, any biologic, any diagnostic, any other device, or any vaccine, used to treat, diagnose, cure, prevent, or mitigate COVID–19, or the transmission of SARS-CoV–2 or a virus mutating therefrom, or any device used in the administration of any such product, and all components and constituent materials of any such product. Covered Countermeasures must be ‘‘qualified pandemic or epidemic products,’’ or ‘‘security countermeasures,’’ or drugs, biological products, or devices authorized for investigational or emergency use, as those terms are defined in the PREP Act, the FD&C Act, and the Public Health Service Act. 

This Federal Register notice anchors the government’s liability protections provided in the various FDA Emergency Use Authorizations (EUAs).


ISEA members are listed here. Many have COVID-19 statements and resources available on their websites.

Federal Government

State & Local Governments

Nonprofit Organizations